Do antiepileptics phenytoin, carbamazepine, and loreclezole show GABAA receptor subtype selectivity in rat brain sections?

作者:

DOI: 10.1023/A:1007688817873

关键词: PhenytoinLigand (biochemistry)LoreclezolePharmacologyAnticonvulsantConvulsantGABAA receptorCarbamazepineReceptorChemistry

摘要: [35S]t-Butylbicyclophosphorothionate ([35S]TBPS), a convulsant site ligand of GABAA receptors, was used in autoradiography with rat brain sections to test suggested receptor subtype-selective actions antiepileptics phenytoin, carbamazepine and loreclezole on native receptors. At maximal 100 μM concentration, both phenytoin decreased [35S]TBPS binding only by 20%, indicating that their low potency efficacy prevents use as α1 subunit-identifying compounds. Ten did not affect the binding, but further increase concentration strongly it. The action loreclezole, assumed reflect β2/3 subunit-containing varied from region region, effects were unrelated regional expression profiles β subunit variants. We conclude autoradiographic assay neither carbamazepine, nor are useful tools characterizing heterogeneity receptors rats exhibits high, pharmacologically relevant efficacy.

参考文章(24)
DJ Laurie, PH Seeburg, W Wisden, The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. The Journal of Neuroscience. ,vol. 12, pp. 1063- 1076 ,(1992) , 10.1523/JNEUROSCI.12-03-01063.1992
W Wisden, DJ Laurie, H Monyer, PH Seeburg, The distribution of 13 GABAA receptor subunit mRNAs in the rat brain − I. Telencephalon, diencephalon, mesencephalon The Journal of Neuroscience. ,vol. 12, pp. 1040- 1062 ,(1992) , 10.1523/JNEUROSCI.12-03-01040.1992
Thomas Kuner, Esa R. Korpi, Peter H. Seeburg, Hartmut Lüddens, Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Molecular Pharmacology. ,vol. 47, pp. 283- 289 ,(1995)
H Luddens, ER Korpi, GABA antagonists differentiate between recombinant GABAA/benzodiazepine receptor subtypes The Journal of Neuroscience. ,vol. 15, pp. 6957- 6962 ,(1995) , 10.1523/JNEUROSCI.15-10-06957.1995
K.A. Wafford, C.J. Bain, K. Quirk, R.M. McKernan, P.B. Wingrove, P.J. Whiting, J.A. Kemp, A novel allosteric modulatory site on the GABAA receptor β subunit Neuron. ,vol. 12, pp. 775- 782 ,(1994) , 10.1016/0896-6273(94)90330-1
E. Persohn, P. Malherbe, J. G. Richards, Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS. The Journal of Comparative Neurology. ,vol. 326, pp. 193- 216 ,(1992) , 10.1002/CNE.903260204
Richard F. Squires, Else Saederup, GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding Brain Research. ,vol. 414, pp. 357- 364 ,(1987) , 10.1016/0006-8993(87)90017-5
J.L DONNELLY, R.L MACDONALD, Loreclezole Enhances Apparent Desensitization of Recombinant GABAA Receptor Currents Neuropharmacology. ,vol. 35, pp. 1233- 1241 ,(1996) , 10.1016/S0028-3908(96)00053-6
P. B. Wingrove, K. A. Wafford, C. Bain, P. J. Whiting, The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 4569- 4573 ,(1994) , 10.1073/PNAS.91.10.4569